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AbstRACt
Objective: To study the determinants of neonatal survival and outcome of preterm deliveries at the Department of Obstetrics 
and Gynaecology, University of Maiduguri Teaching Hospital, Maiduguri, Nigeria.
Materials and Methods: A retrospective case-control study of women who had preterm delivery (PTD) at the UMTH, 
Maiduguri from January 1, 2014 to December 31, 2015 was conducted. Information on socio-demographic characteristics, 
antenatal care and treatment, Apgar score, Special Care Baby Unit (SCBU) and Statistical Package for Social Sciences 
(SPSS) admission and perinatal mortality were collated. Statistical analysis was done with SPSS. Odd ratio was used to test 
for association and multiple logistic regression was computed to control for confounding variables at 95% confidence interval.
Results: A total of 183 preterm births (with 195 babies) and 183 term births (with 184 babies) having complete information 
were analyzed. PTD occurred in 10.38% (19/183) of teenage mothers and 31.16% (68/183) of the PTD were before 32 weeks 
of gestation. Majority of the mothers have had at least basic education (63.69%). The mean duration of admission for the 
preterm babies was 1.9 + 8.4 days with neonatal survival and take home baby rate being 72.31% (141/195). Neonatal 
survival was independently associated with gestational age at delivery >32 weeks (OR = 12.24, CI: 5.67–34.76), antenatal 
dexamethasone (OR = 10.82, CI: 2.38–48.22), pre-labour premature rupture of membranes (OR = 7.68, CI: 1.83–34.64), and 
delivery after at least 24 hour of commencement of dexamethasone (OR = 5.66, CI: 1.23–45.23). However, maternal febrile 
illness (OR = 0.25, CI: 0.11–0.56) and polyhydramnious (OR = 0.29, CI: 0.16–0.55) adversely affected neonatal survival.
Conclusions: The neonatal survival following PTD is high. Survival is more likely in babies born after 32 weeks, PPROM, 
and after antenatal dexamethasone. We recommend routine use of antenatal dexamethasone injection in women at risk of 
PTD and planned delivery at the tertiary centre with equipments to cater for the special needs of the preterm babies.
Key words: Antenatal corticosteroids; determinants; gestational age; preterm delivery; pre-labour premature rupture of 
membranes; perinatal mortality.
Introduction
Preterm delivery (PTD) is the leading cause of perinatal 
morbidity and mortality worldwide with 1.1 million infant 
deaths due to complications of prematurity in 2010.[1] 
Developing countries including Nigeria contribute more 
than 60% of the world’s preterm babies and over 80% of 
global preterm deaths.[1,2] The double misfortune of high 
PTD and low neonatal survival in these areas may be because 
of poor antenatal care, malaria, and other infectious causes 
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of PTD[3–5] coupled with the lack of access to the expensive 
treatments such as surfactant needed by the preterm 
babies as well as poor neonatal intensive care facilities and 
drought of specialist to cater for the special needs of these 
babies.[2] Most of the preterm babies succumb to necrotizing 
enetrocolitis, sepsis, and respiratory problems.[6,7] 
Beyond the neonatal period, survivors have worse neural 
development, poor school performance, increased risk of 
cerebral palsy, and metabolic diseases in adulthood.[8–10]
In addition to good neonatal intensive care facilities, the survival 
of the preterm babies is inversely related to the gestational age 
at delivery and birth weight.[6,7,11] Recently, there is increasing 
advocacy on the use of antenatal steroid to hasten fetal lung 
maturity and improve neonatal survival particularly for women 
that are at risk of delivery before 34 weeks. Administration of 
corticosteroids to women at risk of PTD produce a considerable 
reduction in the risks of complications of prematurity such 
as combined fetal and neonatal death, respiratory distress 
syndrome, cerebroventricular hemorrhage, necrotizing 
enterocolitis, systemic infections, and childhood developmental 
delay.[12,13] Bethamethasone and dexamethasone have been 
shown by various workers to reduce perinatal morbidity and 
mortality for preterm babies.[12,13] In view of the above evidence, 
antenatal dexamethasone injections was enshrined in our 
department protocol for the management of PTD in 2013 but 
its effectiveness has not been reviewed in our hospital.
The antenatal steroid seems to be a viable option in our setting 
because of availability and ease of administration; however, 
this approach is hampered by the difficulty in identifying 
all women at risk of PTD.[14,15] In fact, many of the women 
present to the hospital when delivery is imminent. Other low 
technology modalities such as training community health 
workers in Kangaroo Mother Care (KMC), essential newborn 
care and special care of the moderately preterm baby will go 
a long way in reducing the perinatal mortality.[16] More so that 
preterm babies of African descend tend to be more matured at 
delivery than their Caucasian counterpart and are less likely to 
develop respiratory distress syndrome or require incubator.[8,17]
Earlier studies reviewed the risk factors for PTD with a view 
to modifying them and possibly improve the survival of the 
preterm babies; however, a study by Iyoke et al. in Enugu, 
Nigeria showed poor correlation between the maternal risk 
factors for PTD and perinatal survival.[18] Other researchers 
have found better perinatal survival of the preterm babies with 
increasing gestational age at delivery, higher birth weights as 
well as cesarean delivery than vaginal delivery.[2,19,20]
Knowledge of the factors that determines neonatal survival 
following PTD is vital in counselling women with preterm 
labour and also in preparations to optimize the survival 
for the preterm babies in our settings. To the best of our 
knowledge, no such study had been done in the North-Eastern 
Nigeria. We set out to study the determinants of the outcome 
of preterm births at the UMTH, Maiduguri.
Patients and Methods
A retrospective case-control study of women who had PTD 
at the … from January 1, 2014 to December 31, 2015 was 
carried out. The labour ward register, the Special Care Baby 
Unit (SCBU) register, and case records were used and for 
each PTD, and the next woman that delivered at term was 
recruited as control.
For the purpose of this study, PTD is delivery before 37 
completed weeks, and gestational age was calculated from 
early scan or last menstrual period.
Information on sociodemographic characteristics, risk 
factors for PTD, use of dexamethasone, interval between 
commencement of dexamethasone and delivery, gestational 
age at delivery, mode of delivery, indication for delivery, 
Apgar score, SCBU admission, perinatal mortality, and take 
home baby rate were collated. The information was coded 
and transferred onto a profoma designed for the study. This 
was then transferred onto SPSS version 16 statistical software 
and analyzed. The socio-demographic characteristics, 
pregnancy complications, and birth outcomes are presented 
as percentages on frequency tables. Chi-square test and 
student’s t-test were used to analyze for categorical variables 
and continuous variables, respectively. Multinomial logistic 
regression was used for multivariate analysis to construct 
a model for factors associated with neonatal survival. The 
statistical significance was set at P < 0.05.
Research and Ethics committee of the … granted approval 
for the study.
Results
There were 226 preterm deliveries and 43 had incomplete 
information and were excluded in the analysis. The remaining 
183 preterm births (with 195 babies) were compared with 183 
term births (with 184 babies). PTD occurred in 10.38% (19/183) 
of teenage mothers and 31.16% (68/183) of the PTD were 
before 32 weeks of gestation. Majority of the mothers have 
had at least basic education (63.69%) as shown in Table 1.
The mean duration of admission for the preterm babies was 
1.9 + 8.4 days with neonatal survival and take home baby 
rate of 72.31% (141/195).
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Mode of delivery
Vaginal delivery 116 27
Caesarean section 47 5
Total 163 32






























χ2=1.44, P=0.441 OR=1.68 (CI=0.52-3.89)
Birth interval
<36 months 17 3
>36 months 79 16
Total 96 20
χ2=0.17, P=0.87, OR=1.07 (CI=0.37-3.05)
Table 2 showed the factors associated with neonatal 
survival following PTD. Neonatal survival was significantly 
associated with delivery at or beyond 32 weeks, pre-labour 
premature rupture of membranes (PPROM), previous PTD 
Table 2: Factors associated with neonatal survival after PTD
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and antenatal dexamethsone administration. Maternal 
peripartum febrile illness and polyhydramnious negatively 
affected neonatal survival, as shown in Table 2. Parity, 
pregnancy induced hypertension, mode of delivery, twin 
gestation, HIV infection, booking status, and neonatal sex 
had no statistically significant effect on neonatal survival.
Following multiple logistic regression analysis we found 
that neonatal survival was independently associated with 
Gestational age at delivery >32 weeks (OR = 12.24, CI: 5.67–
34.76), antenatal dexamethasone (OR = 10.82, CI: 2.38–48.22), 
PPROM (OR = 7.68, CI: 1.83–34.64) and delivery after at least 
24 hour of commencement of dexamethasone (OR = 5.66, 
CI: 1.23–45.23). However, maternal febrile illness (OR=0.25, 
CI:0.11-0.56) and polyhydramnious (OR=0.29, CI:0.16-0.55) 
adversely affected neonatal survival as shown in Table 3.
Discussion
PTD is a multi-faceted process, resulting from the interplay 
of factors causing the uterus to change from quiescence 
to active contraction, which leads to delivery before 37 
completed weeks of gestation or purposely induced in the 
interest of the mother, fetus or both, anytime the risk of 
continuing the pregnancy outweigh the risk of delivery. In 
any case neonatal survival is an important consideration 
especially for the couple in guiding their decision.
Our neonatal survival rate of 72.31% after PTD is higher 
than the 65.5% earlier reported in the same centre by Ambe 
et al. in 2007. This improvement can be attributed to the 
use of antenatal dexamethasone during the period under 
review in patients at risk of PTD. It is hoped that with the 
regular use of antenatal corticosteroid we will record better 
survival in the future. Our neonatal survival higher than the 
65.9% recorded in Akure[6] but similar to the 69.9% recorded 
in Sokoto,[7] Nigeria. Both studies did not report the use of 
antenatal corticosteroids.
Neonatal survival is said to be rare before the age of 
24 weeks and exceeds 90% for preterm infants of more 
than 29 weeks in the developed countries.[21,22] However, 
it is very difficult to assign a cut off weeks for neonatal 
survival in our environment but our finding showed that 
babies delivered after 32 weeks are 12 times more likely 
to survive than babies delivered before then. The improved 
survival with increasing gestational age at delivery is not 
surprising because the neonate vital organ’s functionality 
improves progressively with increasing gestational age till 
40 weeks in some cases.[23]
PPROM is a known risk factor for PTD, and in keeping with 
our finding a recent study by Tsafrir et al., found a better 
neonatal outcome in babies born preterm following PPROM 
compared those delivered without PPROM at the same 
gestational age.[24] It has been postulated that PPROM puts 
undue stress on the mother and stressed pregnancies have 
been associated with accelerated fetal lung maturity due 
to increased maternal glucocorticoid levels.[25,26] Hence, the 
conclusion by Tsafrir et al. that women with PPROM after 
32 weeks should be delivered without undue delays in order 
to reduce the risk of chorioamnionitis.[24] The association of 
PPROM with neonatal survival should be taken with caution 
because some studies have found that 25% of PTD are 
associated with intrauterine infection and the risk is more in 
cases with PPROM. Gonclaves et al. found positive cultures in 
32.4% of PTD complicated by PPROM, which further exposes 
the neonate to neonatal sepsis that could jeopardize neonatal 
survival.[27] Other maternal infections including urinary tract 
infections, malaria, bacterial vaginosis, HIV, and syphilis are 
all associated with increased risk of preterm birth and poor 
neonatal outcome.[28] This could explain why peripartum fever 
was found to be associated with poorer neonatal outcome 
in our study and most of the febrile mother tested positive 
for malaria (not shown in the result). A high prevalence of 
both maternal and placental malaria of 30.7% and 33.9%, 
respectively, has been observed earlier in the same centre 
and the placental malaria has been linked to both PTD and 
low birth weight.[29]
Table 3: Multinomial logistic regression analysis model of 
factors associated with neonatal survival following PTD
Factors Odd Ration (95% confidence interval) P
Gestational age at delivery
>32 weeks 12.24 (5.67-34.76) 0.004
<32 weeks -
Antenatal Dexamethasone
Yes 10.82 (2.38-48.22) 0.002
No -
Time interval of steroid
>24 hours 5.66 (1.23-45.23) 0.005
<24 hours -
PROM
Yes 7.68 (1.83-34.64) 0.021
No -
Mode of delivery
Cesarean Section 2.23 (0.63-7.67) 0.27
Vaginal delivery -
Maternal pyrexia
Normal 2.37 (0.78 -6.71) 0.094
Febrile -
Twin gestation
Yes 1.01 (0.18-5.81) 0.85
No -
Birth Interval
>36 months 0.74 (0.15-3.77) 0.79
<36 months -
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We found previous PTD to be associated with better neonatal 
survival and our finding contrast with that of Whiteman et al. 
who found previous PTD to be associated with increased risk 
of neonatal death in subsequent delivery.[30] They argued 
that the risk of subsequent neonatal death may be because 
of worsening prematurity in the subsequent pregnancies 
and it could be a recurrent problem. However, our finding 
of improved survival may be related to the women seeking 
for better neonatal care in their subsequent pregnancies 
particularly in a tertiary health facility where we conducted 
our study. Certainly, a well equipped SCBU will improve 
neonatal survival and majority of these facilities in the 
developing countries are located in the tertiary health 
centres.
Respiratory distress syndrome (RDS) is a common condition 
in premature babies that can lead to mortality[6,7,11,31] and 
a review by Hofmeyr[12] showed that fetal lung maturity 
can be aided by antenatal corticosteroids leading better 
neonatal survival. Our study also confirmed this assertion 
and showed that antenatal dexamethasone is associated 
independently with neonatal survival. This finding is 
important for a developing country like ours where SCBU 
facility like the use of surfactant is either not available 
or very expensive. Dexamethasone is cheap and readily 
available and with the above evidence its utilisation can 
be encouraged even in the primary health care facilities 
upon diagnoses of impending PTD pending referral to the 
tertiary centres for delivery.
Furthermore, the benefit of antenatal dexamethasone 
is seen even in infants born less than 24 hours after 
administration of the first dose[12,32] and this was also seen 
in our study. We found preterm babies delivered 24 hours 
after commencement of the injections to be five times more 
likely to survive than those delivered earlier.
Dexamethasone is not without its untoward effect on the 
neonates as there are reports of hypoglycemia amongst 
exposed neonates.[13,32] This calls for vigilance after delivery 
in order to detect and treat such babies.
Conclusion
The neonatal survival following PTD is 72.31%. Survival is 
more likely in babies born after 32 weeks, PPROM, and at least 
24 hours after antenatal dexamethasone injections. Maternal 
febrile illness and polyhydramnios threatened neonatal 
survival. We recommend routine use of dexamethasone in 
pregnancies at risk of PTD and planned delivery at the tertiary 
centre with equipments to cater for the special needs of the 
preterm babies.
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